Australia markets open in 1 hour 59 minutes

Ion Beam Applications SA (IOBCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
20.00-0.22 (-1.09%)
At close: 3:47PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close20.22
Open20.00
Bid0.00 x 0
Ask0.00 x 0
Day's range20.00 - 20.00
52-week range12.79 - 23.45
Volume518
Avg. volume68
Market cap589.736M
Beta (5Y monthly)0.60
PE ratio (TTM)12.13
EPS (TTM)1.65
Earnings dateN/A
Forward dividend & yield0.24 (1.18%)
Ex-dividend date21 June 2021
1y target estN/A
  • GlobeNewswire

    IBA and the University of Pennsylvania partner to advance research of ConformalFLASH® therapy

    Multi-year research agreement to develop, test and validate ConformalFLASH® at the Roberts Proton Therapy Center Louvain-La-Neuve, Belgium, 25 October 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces that it has signed an agreement with the University of Pennsylvania (Penn) to advance research in ConformalFLASH®1, a novel method combining ultra-high dose rate FLASH radiotherapy and the unique Bragg Peak properties of protons.

  • GlobeNewswire

    Proton Therapy contract finalized with Advocate Radiation Oncology Affiliate in Florida

    Louvain-La-Neuve, Belgium, October 24, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces that its proton therapy contract with Advocate Radiation Oncology, via its affiliate Southwest Florida Proton, has been finalized. IBA will start to recognize revenue from the contract in 2021. The finalization of the contract follows the announcement

  • GlobeNewswire

    IBA launches the world’s first online proton therapy platform

    Campus, IBA’s new interactive platform dedicated to proton therapy, unveiled at ASTRO Louvain-la-Neuve, Belgium, 20 October 2021 - IBA (Ion Beam Applications SA), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces the launch of the world’s first online platform dedicated to proton therapy. The new interactive platform called Campus was unveiled through a series of webinars on October 19-20,